Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TXN vs MRNA✓SelectedUSD · MRNATXN vs MRNA performance historyLatest closeAs of-7.70%11/20
Stock and ETF performance explorer

TXN vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+255.9%
MRNA return
+786.4%
Excess return
-530.5%
Maximum drawdown
-33.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-7.7%-2.2%-5.5%-7.6%
7D-13.1%-12.7%-0.4%-12.6%
30D-6.9%-20.7%+13.8%-6.0%
3M-0.2%+46.3%-46.5%-2.4%
6M-12.6%+305.2%-317.9%-23.4%
YTD+55.3%+561.2%-505.9%+28.9%
1Y+75.8%+772.1%-696.3%+41.8%
3Y+84.0%+147.0%-63.0%+61.3%
5Y+55.5%-26.1%+81.6%+43.3%
All+255.9%+786.4%-530.5%+189.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling